Review



h89 dihydrochloride  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    TargetMol h89 dihydrochloride
    H89 Dihydrochloride, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H-89/pm41462884-81-0-25
    Average 93 stars, based on 11 article reviews
    h89 dihydrochloride - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    95
    MedChemExpress h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H-89+dihydrochloride/pmc13167742-226-6-7
    Average 95 stars, based on 1 article reviews
    h89 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    93
    TargetMol h89 dihydrochloride
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89 Dihydrochloride, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H-89/pm41462884-81-0-25
    Average 93 stars, based on 1 article reviews
    h89 dihydrochloride - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    Tocris drug h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    Drug H89, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H+89+dihydrochloride/pm41903111-159-13-15
    Average 95 stars, based on 1 article reviews
    drug h89 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    Tocris h89 tocris
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89 Tocris, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H+89+dihydrochloride/pm41903111-517-60-61
    Average 95 stars, based on 1 article reviews
    h89 tocris - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    h89  (Tocris)
    95
    Tocris h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H+89+dihydrochloride/pm41812870-311-2-3
    Average 95 stars, based on 1 article reviews
    h89 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc pka inhibitor h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    Pka Inhibitor H89, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H-89%2C+Dihydrochloride/pm41741641-639-44-47
    Average 93 stars, based on 1 article reviews
    pka inhibitor h89 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H-89%2C+Dihydrochloride/pmc13031922-256-10-11
    Average 93 stars, based on 1 article reviews
    h89 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    Tocris h89 dihydrochloride
    Mature neuron activity increases noggin expression and release. ( A ) Noggin mRNA expression levels in neurons cultured 28 days in vitro treated with 20 mM KCl collected at 6 h and 24 h; n = 3, ** p < 0.01. ( B ) Representative western blot probed for noggin protein in neurons cultured 28 DIV treated with 20 mM KCl for 6 h. ( C ) Quantification of western blot probed for noggin showing levels of intracellular noggin after cultured cells were treated with 20 mM KCl for 6 h and 24 h; n = 4, **** p < 0.0001. ( D ) Quantification of extracellular noggin in the media of cultured neurons following 20 mM KCl treatment for 6 and 24 h as assessed by ELISA; n = 4, ** p < 0.01. ( E ) Representative immunocytochemistry showing 28 DIV neurons treated with 20 mM KCl and stained for noggin (green) showing ciliary distribution of noggin staining (indicated by white arrows) at 0 h of treatment, increased ciliary and cytoplasmic noggin expression at 6 h, loss of ciliary noggin distribution and diminished cytoplasmic expression of noggin at 24 h, and return to baseline ciliary distribution of noggin at 72 h. ( F ) Quantification of extracellular noggin in the media of cultured neurons following 20 mM KCl 6 h treatment. Addition of the PKA inhibitor, <t>H89,</t> blocks the effect of KCl depolarization on noggin release; n = 6, ** p < 0.01 Data shown as mean ± SEM. Multiple comparisons test with one-way ANOVA for multiple group experiments. ** p < 0.01; **** p < 0.0001. Scale bars: ( E ): 5 μm.
    H89 Dihydrochloride, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h89+dihydrochloride/H+89+dihydrochloride/pmc12564481-57-3-5
    Average 95 stars, based on 1 article reviews
    h89 dihydrochloride - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and H89 ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit

    doi: 10.1073/pnas.2536312123

    Figure Lengend Snippet: The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and H89 ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.

    Article Snippet: BLU0588 (MedChemExpress, CAS No.: 2810474-78-3) and H89 (MedChemExpress, CAS No.: 130964-39-5) were dissolved in DMSO and stored as a 10 mM stock solution at −80 °C until use.

    Techniques: Comparison, Concentration Assay

    Mature neuron activity increases noggin expression and release. ( A ) Noggin mRNA expression levels in neurons cultured 28 days in vitro treated with 20 mM KCl collected at 6 h and 24 h; n = 3, ** p < 0.01. ( B ) Representative western blot probed for noggin protein in neurons cultured 28 DIV treated with 20 mM KCl for 6 h. ( C ) Quantification of western blot probed for noggin showing levels of intracellular noggin after cultured cells were treated with 20 mM KCl for 6 h and 24 h; n = 4, **** p < 0.0001. ( D ) Quantification of extracellular noggin in the media of cultured neurons following 20 mM KCl treatment for 6 and 24 h as assessed by ELISA; n = 4, ** p < 0.01. ( E ) Representative immunocytochemistry showing 28 DIV neurons treated with 20 mM KCl and stained for noggin (green) showing ciliary distribution of noggin staining (indicated by white arrows) at 0 h of treatment, increased ciliary and cytoplasmic noggin expression at 6 h, loss of ciliary noggin distribution and diminished cytoplasmic expression of noggin at 24 h, and return to baseline ciliary distribution of noggin at 72 h. ( F ) Quantification of extracellular noggin in the media of cultured neurons following 20 mM KCl 6 h treatment. Addition of the PKA inhibitor, H89, blocks the effect of KCl depolarization on noggin release; n = 6, ** p < 0.01 Data shown as mean ± SEM. Multiple comparisons test with one-way ANOVA for multiple group experiments. ** p < 0.01; **** p < 0.0001. Scale bars: ( E ): 5 μm.

    Journal: Cells

    Article Title: Neuronal Primary Cilia Mediate Noggin Release to Enable Extracellular Signaling

    doi: 10.3390/cells14201607

    Figure Lengend Snippet: Mature neuron activity increases noggin expression and release. ( A ) Noggin mRNA expression levels in neurons cultured 28 days in vitro treated with 20 mM KCl collected at 6 h and 24 h; n = 3, ** p < 0.01. ( B ) Representative western blot probed for noggin protein in neurons cultured 28 DIV treated with 20 mM KCl for 6 h. ( C ) Quantification of western blot probed for noggin showing levels of intracellular noggin after cultured cells were treated with 20 mM KCl for 6 h and 24 h; n = 4, **** p < 0.0001. ( D ) Quantification of extracellular noggin in the media of cultured neurons following 20 mM KCl treatment for 6 and 24 h as assessed by ELISA; n = 4, ** p < 0.01. ( E ) Representative immunocytochemistry showing 28 DIV neurons treated with 20 mM KCl and stained for noggin (green) showing ciliary distribution of noggin staining (indicated by white arrows) at 0 h of treatment, increased ciliary and cytoplasmic noggin expression at 6 h, loss of ciliary noggin distribution and diminished cytoplasmic expression of noggin at 24 h, and return to baseline ciliary distribution of noggin at 72 h. ( F ) Quantification of extracellular noggin in the media of cultured neurons following 20 mM KCl 6 h treatment. Addition of the PKA inhibitor, H89, blocks the effect of KCl depolarization on noggin release; n = 6, ** p < 0.01 Data shown as mean ± SEM. Multiple comparisons test with one-way ANOVA for multiple group experiments. ** p < 0.01; **** p < 0.0001. Scale bars: ( E ): 5 μm.

    Article Snippet: The PKA inhibitor, H89 dihydrochloride (Tocris Bioscience, Bristol, UK, Cat. No. 2910) solid, was dissolved in PBS at a working concentration of 100 μM and used at a final concentration of 20 μM in prepared media.

    Techniques: Activity Assay, Expressing, Cell Culture, In Vitro, Western Blot, Enzyme-linked Immunosorbent Assay, Immunocytochemistry, Staining